Your browser doesn't support javascript.
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol.
Sen, Parikshit; Gupta, Latika; Lilleker, James B; Aggarwal, Vishwesh; Kardes, Sinan; Milchert, Marcin; Gheita, Tamer; Salim, Babur; Velikova, Tsvetelina; Gracia-Ramos, Abraham Edgar; Parodis, Ioannis; O'Callaghan, Albert Selva; Nikiphorou, Elena; Tan, Ai Lyn; Cavagna, Lorenzo; Saavedra, Miguel A; Shinjo, Samuel Katsuyuki; Ziade, Nelly; Knitza, Johannes; Kuwana, Masataka; Cagnotto, Giovanni; Nune, Arvind; Distler, Oliver; Chinoy, Hector; Aggarwal, Vikas; Aggarwal, Rohit.
  • Sen P; Maulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, Delhi, 110002, India.
  • Gupta L; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareilley Road, Lucknow, 226014, India. drlatikagupta@gmail.com.
  • Lilleker JB; Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, WV10 0QP, UK. drlatikagupta@gmail.com.
  • Aggarwal V; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • Kardes S; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.
  • Milchert M; Mahatma Gandhi Mission Medical College, Navi Mumbai, Maharashtra, India.
  • Gheita T; Department of Medical Ecology and Hydroclimatology, Istanbul Faculty of Medicine, Istanbul University, Capa-Fatih, Istanbul, 34093, Turkey.
  • Salim B; Department of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University, ul Unii Lubelskiej 1, 71-252, Szczecin, Poland.
  • Velikova T; Rheumatology Department, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
  • Gracia-Ramos AE; Rheumatology Department, Fauji Foundation Hospital, Rawalpindi, Pakistan.
  • Parodis I; Department of Clinical Immunology, Medical Faculty, University Hospital "Lozenetz", Sofia University St. Kliment Ohridski, 1 Kozyak Str., Sofia, 1407, Bulgaria.
  • O'Callaghan AS; Department of Internal Medicine, General Hospital, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Av. Jacaranda S/N, Col. La Raza, Del. Azcapotzalco, C.P. 02990, Mexico City, Mexico.
  • Nikiphorou E; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Tan AL; Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Cavagna L; Internal Medicine Department, Vall D'hebron General Hospital, Universitat Autonoma de Barcelona, 08035, Barcelona, Spain.
  • Saavedra MA; Centre for Rheumatic Diseases, King's College London, London, UK.
  • Shinjo SK; Rheumatology Department, King's College Hospital, London, UK.
  • Ziade N; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Knitza J; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • Kuwana M; Rheumatology Unit, Dipartimento di Medicine Interna e Terapia Medica, Università Degli Studi di Pavia, Pavia, Lombardy, Italy.
  • Cagnotto G; Departamento de Reumatología Hospital de Especialidades Dr. Antonio Fraga Mouret, Centro Médico Nacional La Raza, IMSS, Mexico City, Mexico.
  • Nune A; Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, SP, Brazil.
  • Distler O; Rheumatology Department, Saint-Joseph University, Beirut, Lebanon.
  • Chinoy H; Rheumatology Department, Hôtel-Dieu de France Hospital, Beirut, Lebanon.
  • Aggarwal V; Medizinische Klinik 3 - Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.
  • Aggarwal R; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8602, Japan.
Rheumatol Int ; 42(1): 23-29, 2022 01.
Article in English | MEDLINE | ID: covidwho-1516851
ABSTRACT
The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rheumatol Int Year: 2022 Document Type: Article Affiliation country: S00296-021-05046-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rheumatol Int Year: 2022 Document Type: Article Affiliation country: S00296-021-05046-4